나눔터
공지사항
의학정보
복지정책
환우회소식
회비 및 후원금 납부내역
헌팅턴병 메뉴얼
HOME > 나눔터 > 의학정보

작성자
huntington [작성일 : 2016-03-25 10:33:50 ]   
제목 헌팅턴병 동물에서 사람의 줄기세포를 이용한 성공적 치료 결과에 대한 내용 글 올립니다.


최근 줄기세포에 신경보호 인자를 분비하게 조정하여 헌팅턴병 동물에 적용한 연구결과가 보고되었습니다. 동물에서는 많은 줄기세포 연구가 좋은 결과를 보이고 있으나 사람에 적용하는 것이 큰 해결과제로서 아직까지 큰 난제로 여겨집니다. 궁극적으로 줄기세포를 이용한 치료제 개발이 필요하고 많은 성과들이 보고 되고 있어, 현시점에서는 임상시험 단계에서 개발되고 있으나, 지금의 연구개발 성과를 고려 10-20년 뒤에는 줄기세포가 실제 치료제로 적용될 수 있는 전환점을 맞지 않을까 생각해 봅니다.  


Mice with Huntington's Disease Successfully Targeted by Human Stem Cells, UC Researchers Say ~


Huntington's disease, a fatal neurodegenerative disease, is characterized by

the progressive neuronal loss in the striatum, a brain area involved in

motor and behavioral control, followed by generalized brain atrophy.

Striatal neuron loss is responsible for some of the more serious

Huntington's symptoms, such as impaired movement control, cognitive decline,

and severe behavioral disorders. Brain-derived neurotrophic factor (BDNF),

found to be reduced in Huntington's post-mortem human brains, is a promising

lead candidate for treatment of the disease, as it has been shown to prevent

neuron death and to stimulate the growth and migration of brain cells in the

brains of mouse models.

Mesenchymal stem cells (MSCs) have been shown to be effective in delivering

BDNF to mouse brains because they are not rejected by the immune system, as

it may occur with viruses, and they are attracted to sites of injury,

releasing other factors that reduce inflammation and enhance connection

between neurons. However, the use of human MSCs in mouse models has been

hampered by mouse immune systems, which rejects these foreign cells.

Researchers were now able to overcome these setbacks, advancing the

potential of the BDNF/MSC platform for clinical applications.

 

The UC Davis team designed a system to immuno-suppress mouse models of

Huntington's disease to successfully test the efficacy of BDNF delivery by

human MSCs. First, researchers isolated MSCs from healthy human bone marrow

donors and engineered them to secrete elevated amounts of BDNF. The grown

population of MSCs was then injected into the brains of Huntington's mouse

models, who were then tested weekly for behavioral changes and degeneration.

Mice injected with MSCs, compared to those injected with a placebo, showed

significantly less anxiety, a hallmark characteristic of Huntington's. In

addition, mice treated with MSCs showed less degeneration in the striatum,

increased neuron growth activity, and an extended lifespan, by 15 percent,

when com pared with control mice.

 

These results are an important step for researchers to get U.S. Food and

Drug Administration approval to test the therapy's safety and efficacy in

human patients with the disease. "For the first time, human stem cells have

been successfully used as a platform to deliver brain-derived neurotrophic

factor (BDNF), the growth factor that shows great promise for treating

Huntington's disease," principal investigator Prof. Vicki Wheelock said in a

news release <http://www.ucdmc.ucdavis.edu/publish/news/newsroom/10872> .

"We must complete additional animal studies before we can apply for

regulatory approval to test this therapy in Huntington's patients, but the

results we've seen using the human cell products in mouse models of the

disease are very encouraging."

 

==========================

 

 

 

Subject Category: Cell Therapy

 

Human Mesenchymal Stem Cells Genetically Engineered to Overexpress  Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease  Mouse Models

 

http://www.nature.com/mt/journal/vaop/ncurrent/full/mt201612a.html

   

Abstract: Huntington's disease (HD) is a fatal degenerative autosomal

dominant neuropsychiatric disease that causes neuronal death and is

characterized by progressive striatal and then widespread brain atrophy.

Brain-derived neurotrophic factor (BDNF) is a lead candidate for the

treatment of HD, as it has been shown to prevent cell death and to stimulate

the growth and migration of new neurons in the brain in transgenic mouse

models. BDNF levels are reduced in HD postmortem human brain. Previous

studies have shown efficacy of mesenchymal stem/stromal cells (MSC)/BDNF

using murine MSCs, and the present study used human MSCs to advance the

therapeutic potential of the MSC/BDNF platform for clinical application.

Double-blinded studies were performed to examine the effects of

intrastriatally transplanted human MSC/BDNF on disease progression in two

strains of immune-suppressed HD transgenic mice: YAC128 and R6/2. MSC/BDNF

treatment decreased striatal atrophy in YAC128 mice. MSC/BDNF treatment also

significantly reduced anxiety as measured in the open-field assay. Both MSC

and MSC/BDNF treatments induced a significant increase in neurogenesis-like

activity in R6/2 mice. MSC/BDNF treatment also increased the mean lifespan

of the R6/2 mice. Our genetically modified MSC/BDNF cells set a precedent

for stem cell-based neurotherapeutics and could potentially be modified for

other neurodegenerative disorders such as amyotrophic lateral sclerosis,

Alzheimer's disease, and some forms of Parkinson's disease. These cells

provide a platform delivery system for future studies involving corrective

gene-editing strategies.

 

 

[ 새글 | 답글 | 수정 | 삭제 ] [ 목록 ]
[ 총게시물 : 120 | page : 6 ]
[ 정렬조건 : 등록일 | 조회  ]
순번 제목 조회 파일 등록일 작성자
20   헌팅턴병 약물 개발 기사글 올립니다. 2791 16/03/26 운영자  
19   헌팅턴병 동물에서 사람의 줄기세포를 이용한 성공적 치료 결과에 대한 2813 16/03/25 운영자  
18   헌팅턴병 치료 약물 연구개발에 대한 소개글 올립니다. 1749 16/03/07 운영자  
17   김만호 교수님 세계헌팅턴병 학회 참관기를 올립니다. 2414 16/03/03 운영자  
16   헌팅턴병 처방을 위한 치료제가 이제 곧 멀지 않았다는 내용의 기사글을... 5064 16/02/13 운영자  
15   바이러스 이용한 헌팅턴병 치료 연구글 소개합니다. 1528 16/01/15 운영자  
14   치매 정복의 길 여는 치료제 2018년께 출시 2844 16/01/04 운영자  
13   세계 헌팅턴병 커뮤니티에서 발행하는 헌팅턴병 연구 소식지를 올립니다... 2372 15/12/04 운영자  
12   전기자극을 이용한 헌팅턴병 증상 완화에 대한 글을 소개합니다. 1853 15/11/30 운영자  
11   안티센스 올리고핵산(ASO; antisense oligonucleotide) 기술을 근간으로... 5179 15/11/23 운영자  
10   화이자 회사의 헌팅턴병 처치 약물 설명회에 대한 소개글 입니다. 2314 15/11/11 운영자  
9   유전자 편집을 이용한 사람에서 최초 유전자치료 1797 15/11/06 운영자  
8   헌팅턴병 새로운 약 승인과 기존 약에 대한 정보 소개합니다. 2504 15/11/03 운영자  
7   헌팅턴병 동물 모델에서 유전자 조작을 이용한 치료 효과 확인 2884 15/10/30 운영자  
6   유전자 조절 치료제 약 개발에 대하여 2206 15/10/26 운영자  
5   헌팅턴병 증상을 검사하는 새로운 방법에 대한 보고입니다. 2047 15/10/20 운영자  
4   초기 헌팅턴병 치료를 위한 연구 소개글 입니다. 1635 15/10/16 운영자  
3   '만능 줄기세포+유전자 가위'…유전성 정신지체 치료 길 열어 1746 15/10/05 운영자  
2   헌팅턴병 간병 메뉴얼 (영문) 1877 15/09/23 운영자  
1   헌팅턴병 병에 대해서 2494 15/09/21 운영자  

1 2 3 4 5 6 [ 새글 | 처음목록 | 목록 ]  
단체명 : 헌팅턴병 환우회   주소 : 서울시 종로구 연건동 서울대학교병원  

Copyrightⓒ by huntington.co.kr All rights reserved.    webmaster  개인정보 취급방침